Interferon-gamma in the treatment of superficial and recurrent bladder carcinoma. Phase one study
Fontana, G.; Caccia, P.; Alladio, F.; Laudi, M.; Pigato, M.; Sesia, G.; Forni, G.; Giovarelli, M.
Progress in Clinical and Biological Research 303: 479-480
1989
ISSN/ISBN: 0361-7742 PMID: 2506557 Document Number: 333418
Document emailed within 1 workday
Related Documents
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294Huncharek, M.; McGarry, R.; Kupelnick, B. 2001: Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis Anticancer Research 21(1b): 765-769
Barzacchi, M.C.; Nobile, M.T.; Sanguineti, O.; Sertoli, M.R.; Chiara, S.; Repetto, L.; Forno, G.; Lavarello, A.; Rosso, R. 1994: Treatment of metastatic colorectal carcinoma with lymphoblastoid interferon and 5-fluorouracil: data of a phase Ii study Anticancer Research 14(5b): 2147-2149
Tsukagoshi, S. 2003: ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(7): 1027-1038
Horvath, G.; Stendahl, U.; Kalling, M.; Fernö, M.; Himmelmann, A.; Hajba, A. 1990: Antiestrogenic treatment of advanced and recurrent carcinoma corporis uteri--a phase Ii study of toremifene Anticancer Research 10(2a): 323-325
Miura, H.; Arai, H.; Matsuoka, A.; Yazawa, K.; Satoh, E.; Nishimura, K.; Honda, M.; Fujioka, H. 1999: Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy Hinyokika Kiyo. Acta Urologica Japonica 45(2): 79-83
Cockett, A.T.; Merguerian, P.A.; di Sant'Agnese, P.A.; Wheeless, L.L. 1989: Immunotherapy for the treatment of superficial and infiltrative bladder carcinoma Progress in Clinical and Biological Research 303: 455-462
Creagan, E.T.; Ahmann, D.L.; Long, H.J.; Frytak, S.; Sherwin, S.A.; Chang, M.N. 1987: Phase Ii study of recombinant interferon-gamma in patients with disseminated malignant melanoma Cancer Treatment Reports 71(9): 843-844
Gruenwald, I.; Stein, A.; Lurie, A. 1995: Conservative treatment of superficial transitional cell carcinoma of the bladder Harefuah 128(2): 104-111
Werner, W.; Smesny, S.; Schubert, J. 2000: Modern follow-up strategies for the treatment of patients with superficial bladder carcinoma Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 94(6): 519-527
Huland, H.; Otto, U. 1983: Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of a controlled, prospective study in 58 patients European Urology 9(2): 84-86
Moyano Calvo, J.L.; Teba del Pino, F.; Sanz Sacristán, J.; Fernández Arjona, M.; Arellano Gañan, R.; Rabadán Ruiz, M.; Herrero Torres, L.; Melón Rey, F.J.; Pereira Sanz, I. 1995: Immunoprophylaxis of superficial tumors of the bladder with interferon alfa-2b. our experience Archivos Espanoles de Urologia 48(1): 55-59
Kotake, T.; Koyanagi, T.; Akaza, H.; Shimazaki, J.; Ito, H.; Hosaka, M.; Okajima, E.; Saito, Y.; Miyanaga, N.; Kuroda, M.; Hirao, Y. 1998: Results of clinical study with epirubicin hydrochloride injectable solution for superficial bladder cancer. IMI28 Injectable Solution Study Group for Superficial Bladder Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(8): 1189-1195
Yoshida, K.; Takahashi, T.; Nakame, Y.; Saitoh, H.; Horiuchi, S.; Kaneoya, F.; Negishi, T. 1987: Bladder instillation of verapamil as a means of enhancing the efficacy of chemotherapy in superficial bladder carcinoma: influence of bladder instillation of verapamil on the cardiovascular system Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(2): 506-510
Morisaki, T.; Matsunaga, H.; Beppu, K.; Ihara, E.; Hirano, K.; Kanaide, H.; Mori, M.; Katano, M. 2000: A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells Anticancer Research 20(5b): 3363-3373
Hanus, M.; Matousková, M. 1994: Location of primary and recurrent superficial bladder tumors and benefits of selective biopsies Neoplasma 41(2): 119-122
Nakagawa, S.; Kojima, M.; Takada, H.; Sugimoto, K.; Mikami, K.; Watanabe, H. 1992: Short-duration bladder instillation therapy with pirarubicin for superficial bladder tumor based on pharmacodynamic study Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(11): 1873-1877
Kob, D.; Lilienthal, A.; Bauhardt, H.; Merkle, K.; Schröder, E.; Schröder, E.; Hentschel, M. 1991: The radiation-sensitizing effect of isometronidazole following its intravesical application in bladder carcinoma. a clinical phase-Ii study Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 167(9): 530-533
Cunningham, A.L.; Merigan, T.C. 1984: Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis Journal of Immunology 132(1): 197-202
Bandhauer, K.; Bischof, B. 1985: Superficial papillary bladder cancer and carcinoma in situ Helvetica Chirurgica Acta 52(3-4): 467-468